Raloxifene

Evista

SERM aas Oral FDA/EMA Label

Half-life

27.7 hr

Time to Peak

6 hr

Steady State

~6 days

Bioavailability

Dose Range

30–120 mg

Frequency

Daily

Overview

SERM often preferred over tamoxifen specifically for gynecomastia treatment. Community reports suggest better gyno reduction with fewer side effects than tamoxifen.

Mechanism of Action

Second-generation SERM — estrogen antagonist at breast tissue and uterine tissue, agonist at bone. Does not increase uterine cancer risk like tamoxifen.

Dosing Information

Route	Dose Range	Half-life	Tmax	Frequency
Oral	30–120 mg	27.7 hr	6 hr	Daily

Used in Regimens

Raloxifene is not currently part of any catalog regimen.

Data Sources

FDA Label Evista (raloxifene) FDA Prescribing Information

Related Tools

Medication Level Plotter

See blood level curves for this compound

Dose Calculator

Calculate reconstitution and draw volumes

Split Dose Calculator

Divide your weekly dose into multiple injections

Track Raloxifene with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.